Drugs / Inulin
Inulin
also known as
Chicory root inulin · Fruitafit Inulin · Inulin and sodium chloride · Inulin component of iqp-ae-103
Regulatory milestones approvals, filings & regulatory actions · 1 recorded
| Milestone | Jurisdiction | Brand | Indication | Date | Sentence it was read from |
|---|---|---|---|---|---|
| Approved | US (FDA) | INULIN AND SODIUM CHLORIDE | — | 1940-04-30 | fda.gov ↗ |
Trials 13
1938193919401941194219431944194519461947194819491950195119521953195419551956195719581959196019611962196319641965196619671968196919701971197219731974197519761977197819791980198119821983198419851986198719881989199019911992199319941995199619971998199920002001200220032004200520062007200820092010201120122013201420152016201720182019202020212022202320242025202620272028202920302031203220332034
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 02 trials | ||||||
| Phase 0 | NCT06347198 | Apr → Dec 2024 | colorectal cancer | Union Hospital, Tongji Medical College, Huazhong University of Science and Technology | Unknown | No outcome recorded |
| Phase 0 | NCT05277090 | Mar 2022 | — | Yanqing Li | Unknown | No outcome recorded |
| Phase 1/23 trials | ||||||
| Phase 1/2 | NCT06866262 | Aug 2025 → Aug 2031 expected | clear cell renal carcinoma, sarcomatoid renal cell carcinoma | University of Michigan Rogel Cancer Center | Recruiting | No outcome recorded |
| Phase 1/2 | NCT03894449 | Apr → Jul 2019 | iron deficiency anemia | University of Veterinary and Animal Sciences, Lahore - Pakistan | Completed | No outcome recorded |
| Phase 1/2 | NCT01588756 | Oct 2010 → May 2015 | chronic kidney disease | Assistance Publique - Hôpitaux de Paris | Completed | No outcome recorded |
| Phase 25 trials · 1 missed | ||||||
| Phase 2 | NCT07189585 | Nov 2026 → Jul 2027 expected | osteoarthritis, knee | Yale University | Not yet recruiting | No outcome recorded |
| Phase 2 | NCT03865706 | Oct 2019 → Nov 2023 | bacterial infectious disease, infectious disease with sepsis, nosocomial infection, nutritional disorder | Columbia University | Completed | Missed primary |
| Phase 2 | NCT03630588 | Aug → Dec 2018 | obesity disorder | Technological Centre of Nutrition and Health, Spain | Completed | No outcome recorded |
| Phase 2 | NCT02794766 | Mar 2014 → May 2015 | tongue disorder | Universidade de Passo Fundo | Completed | No outcome recorded |
| Phase 2 | NCT00319007 | Apr → Dec 2006 | classic or attenuated familial adenomatous polyposis | Radboud University Medical Center | Unknown | No outcome recorded |
| Phase 41 trial | ||||||
| Phase 4 | NCT04698330 | May 2022 → Dec 2025 overdue | latent autoimmune diabetes in adults | Second Xiangya Hospital of Central South University | Not yet recruiting | No outcome recorded |
| Phase not applicable2 trials | ||||||
| — | NCT06738550 | Mar 2023 → Jul 2024 overdue | chronic kidney disease, constipation disorder | NIN Institute | Enrolling by invitation | No outcome recorded |
| — | NCT04421313 | Sep 2020 → Oct 2024 | rheumatoid arthritis | University Hospital, Montpellier | Unknown | No outcome recorded |
| Comparator or background therapy3 trials | ||||||
| Phase 2 | NCT06372249 Comparator | Nov 2025 → May 2027 expected | childhood onset asthma | Phoenix Children's Hospital | Recruiting | No outcome recorded |
| Phase 4 | NCT04118010 Comparator | Mar 2020 → Dec 2022 | cystic fibrosis | Emory University | Completed | No outcome recorded |
| — | NCT00431665 Background | Jul 1999 → Jun 2000 | — | Medical University of Vienna | Completed | No outcome recorded |
Evidence & citations 7 cited values
Every value below carries the sentence it was read from. 17 sources stand behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | Inulin | “A combination dosage of prebiotic (Inulin or GOS) and Iron Fortificant (FeSO4 or NaFeEDTA) will be given to the study subjects.” NCT03894449 ↗15“Inulin (3.4 grams per 100 grams of surimi, 1.7 grams per 50 grams of surimi): Obtained from Chicory originating in Europe.” NCT03630588 ↗ “12 g of inulin or of maltodextrin in powder, to dilute in water once daily, during 1 month.” NCT04421313 ↗ “agave inulin supplementation is provided 9 gr per day” NCT06738550 ↗ “Inulin” NCT06866262 ↗ |
| Known as | Chicory root inulin | ChEMBL registry synonym — accepted as the source's own label CHEMBL1201646 ↗ |
| Known as | Fruitafit Inulin | “Randomized controlled trial of soluble fiber (Fruitafit Inulin).” NCT06372249 ↗ |
| Known as | Inulin and sodium chloride | ChEMBL registry synonym — accepted as the source's own label CHEMBL1201646 ↗ |
| Known as | Inulin component of iqp-ae-103 | ChEMBL registry synonym — accepted as the source's own label CHEMBL1201646 ↗ |
| Modality | Other / unclassified | “Inulin (probiotic)” NCT00319007 ↗ |
| Route | Intravenous | “AcSDKP-NH2 inuline, Once intravenous administration of 100 µg or less” NCT01588756 ↗ |